This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the scale and intensity of patent activity, identifying areas of technological specialisation, and assessing the level of collaboration, the report provides an overview of pharmaceutical innovation in Australia.
Publications & reports
This paper uses an open database, Intellectual Property Government Open Data (IPGOD), which matches the Australian IP registries to firm level data, in combination with world patent databases to detail the patent filing activity and innovation areas in the mining sector.
The Economic Impact of Innovation Patents report assesses how effective the innovation patent has been at achieving its objectives through analysis of applicant filing behaviour and a range of econometric tests. This report uses IP Australia’s administrative data to conduct an economic review of the innovation patent system.
This report provides a collation of data and information about the IP system in Australia, where Australia sits in the global IP system, and how it measures up against other countries. It is the third Intellectual Property report release from IP Australia.
The global medical devices market is valued at approximately US$325 billion. In 2012, the Australian industry had turnover of $10 billion, with exports of over $2.1 billion in 2013-2014.
The goal of this study is to provide insights into how the market for design operates.
Our project is the first stage in mapping the dynamics and mechanisms of how the market for design operates. Our ultimate aim is to generate insights that inform how Australia might encourage the growth of design as a capability within firms.